Patent Baristas

The World Intellectual Property Organization (WIPO) has published a manual entitled “Exchanging Value – Negotiating Technology Licensing Agreements,” which provides a review of some of the basic issues that arise in licensing negotiations of intellectual property, particularly patents. The publication offers a practical introduction to negotiating licensing agreements and is designed to address the needs […]

The Baristas have updated their look and gotten a new attitude.  Thanks to Barbara, at CaricatureConnection, we now have new images on our Get to Know Your Baristas page.  We’ll be brewing up news and comments on a regular basis and appreciate your comments and suggestions. Let us know if you like our new look.  […]

Stephen and I attended a breakfast meeting on Wednesday morning. It started at 8:00 A.M. He was there on time. He is very good at that. I, of course, was late as usual. BT (before toddlers), I was either early or on time. AT (you can figure out what it stands for), I feel like […]

As tipped off by Dennis Crouch’s Patently Obvious blog, the U.S. Government Department of Health & Human Services (HHS) has requested an inter-partes reexamination of U.S. Pat. No. 6,653,104 for an anti-cancer antibody assigned to Immunomedics, Inc. See the OG Notice here.

Well, somehow I managed to miss the next round of American Idol this past Wednesday night and found myself watching 60 Minutes Wednesday night edition, with their interview of Dr. David Graham. Dr. Graham is a senior scientist within the FDA’s Office of Drug Safety and now a whistleblower at the FDA. Graham blames the […]

Blogger and Patent Attorney Axel H Horns posted a nice review of the recent EU-CREST Committee on “IPR and Research” report. The Committee for Scientific and Technical Research (Crest) is the advisory committee to the Council and the Commission on subjects relating to scientific and technical research and in particular, on the co-ordination of national […]

The Washington Post reported that the USPTO rejected a patent on a human hybrid. Stuart Newman of New York Medical College tried to patent a hybrid designed for use in medical research but not yet created. The USPTO stated that the hybrid would be too closely related to a human to be patentable. The inventor […]

It hasn’t a great month for the Big Pharmas when it comes to battling the on-slaught of generics. Despite being the time for Valentines and amore, Pfizer is feeling blue since the Technical Board of Appeal revoked Pfizer’s “Viagra-Patent” EP-0 702 555 by dismissing the appeal against an earlier lost.